Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.
Sign Up to like & getrecommendations! Published in 2023 at "Endocrine journal"
DOI: 10.1507/endocrj.ej22-0585
Abstract: In Japan, the standard method for measuring plasma aldosterone concentration (PAC) for primary aldosteronism (PA) diagnosis was changed from radioimmunoassay (RIA) to a novel chemiluminescent enzyme immunoassay (CLEIA). The purpose of this study is to… read more here.
Keywords: aldosterone; diagnosis; plasma aldosterone; primary aldosteronism ... See more keywords